Back to Search
RACHEL HARTMANN, DMD
DMD
General Practice Dentistry
NPI: 1861186231Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
D.007169-C1(AL)
Research & Publications (20)
Factor IX mutants with enhanced catalytic activity.
PMID 19656280·J Thromb Haemost·2009
4-observational
The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain.
PMID 18931074·J Gen Virol·2008
7-preclinical
Cytotoxic and allergenic potential of bioactive proteins and peptides.
PMID 17430189·Curr Pharm Des·2007
6-review
Food-derived peptides with biological activity: from research to food applications.
PMID 17292602·Curr Opin Biotechnol·2007
6-review
[Designing a surgical device for harvesting autologous fascia lata grafts as a minimal invasive procedure].
PMID 16961455·Biomed Tech (Berl)·2006
8-other
Tailor-made olefinic medium-chain-length poly[(R)-3-hydroxyalkanoates] by Pseudomonas putida GPo1: batch versus chemostat production.
PMID 16255038·Biotechnol Bioeng·2006
4-observational
CYP 17 and CYP 19 inhibitors. Evaluation of fluorine effects on the inhibiting activity of regioselectively fluorinated 1-(Naphthalen-2-ylmethyl)imidazoles.
PMID 15449729·J Enzyme Inhib Med Chem·2004
8-other
Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis.
PMID 12750023·Eur J Med Chem·2003
7-preclinical
Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase.
PMID 14636576·Mol Cell·2003
7-preclinical
Inhibition of CYP 17, a new strategy for the treatment of prostate cancer.
PMID 12112031·Arch Pharm (Weinheim)·2002
6-review
Inhibition of 2'-5' oligoadenylate synthetase by divalent metal ions.
PMID 11682059·FEBS Lett·2001
7-preclinical
Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2.
PMID 11063622·J Med Chem·2000
7-preclinical
Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17).
PMID 11087568·J Med Chem·2000
7-preclinical
Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C.
PMID 19583211·Biochemistry·2009
7-preclinical
3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
PMID 19606904·J Med Chem·2009
8-other
How do we reduce the number of cases of missed postpartum diabetes in women with recent gestational diabetes mellitus?
PMID 19641163·Diabetes Care·2009
4-observational
Development and evaluation of a FACS-based medium-throughput assay for HCV entry inhibitors.
PMID 19531666·J Biomol Screen·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1064 INDUSTRIAL PKWY
SARALAND, AL 36571 - Phone
- (251) 675-4313
Quick Facts
- NPI
- 1861186231
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile